TRex Bio, Inc. Form 424B4 — Oct 9, 2026

Form 424B4Filed Oct 9, 2026, 5:03 PM ET0001193125-26-419203Original filing

TRex Bio priced its IPO at $14.00 per share, selling 8,333,334 shares for gross proceeds of ~$116.7 million (~$103.5M net), with underwriters holding a 30-day option on 1,250,000 additional shares. The stock is expected to list on Nasdaq under "TRXB," with J.P.

Key figures

Greenshoe: 1250000
Cash Position: 90854000
Gross Proceeds: 116666676
Offering Price: 14
Shares Offered: 8333334
Shares Outstanding: 27445682
Runway: into the second half of 2029
Net Proceeds: approximately $103.5 million (or ~$119.8 million if greenshoe exercised)
Nasdaq Symbol: TRXB
Reverse Split Ratio: 1-for-3.8649 (effected October 2, 2026)
Proceeds Before Expenses: 108500009
Total Assets Pro Forma Adjusted: 198684000
Underwriting Discount Per Share: 0.98

AI analysis

Red flags6 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.